vaccin
one
effect
costbenefici
intervent
prevent
mortal
reduc
morbid
caus
pathogen
influenza
virus
improv
host
immun
respons
continu
emerg
viral
threat
vaccin
technolog
continu
put
great
effort
integr
viruslik
featur
vaccin
formul
recent
studi
illustr
vaccin
preserv
viruslik
featur
show
better
capabl
elicit
immun
respons
comparison
tradit
vaccin
formul
recent
year
nanoparticl
consid
interest
compon
experiment
vaccin
formul
use
nanoparticl
vaccinolog
inspir
fact
pathogen
dimens
nanos
rang
therefor
process
effici
immun
system
lead
potent
immun
respons
therefor
nanoparticl
exploit
elicit
desir
immun
respons
prophylact
therapeut
effect
util
either
deliveri
system
enhanc
antigen
process
protect
antigen
prematur
degrad
andor
immun
stimul
trigger
immun
respons
nanotechnolog
allow
custom
nanoparticl
properti
size
shape
surfac
charg
meet
applic
requir
result
signific
varieti
nanoparticl
nanodiamond
nd
carbon
nanomateri
appli
mani
field
research
excel
mechan
optic
properti
high
surfac
area
tunabl
surfac
structur
biocompat
nanomateri
well
suit
biomed
applic
previou
studi
shown
strong
acidoxid
nd
remark
high
affin
protein
thu
protein
nd
form
stabl
conjug
easili
effect
differ
buffer
via
physic
absorpt
also
uniqu
solubl
protein
nativ
membran
protein
solubil
deterg
micel
easili
conjug
onto
surfac
nd
like
due
intrins
hydrophob
carbonbas
nanomateri
characterist
allow
facil
effect
load
high
amount
protein
molecul
surfac
biomed
applic
nm
nd
weight
nanoparticl
carri
dri
weight
protein
influenza
virus
seriou
global
pathogen
deem
one
biggest
threat
human
anim
health
avian
influenza
viru
emerg
new
human
pathogen
china
spring
februari
human
infect
case
report
includ
death
virus
along
mani
emerg
influenza
subtyp
challeng
scientist
develop
faster
efficaci
vaccin
haemagglutinin
ha
major
protein
influenza
viru
envelop
contain
virusneutr
epitop
includ
current
approv
human
influenza
vaccin
well
major
experiment
vaccin
nativ
influenza
ha
protein
polymer
trimer
seem
recombin
ha
fragment
easili
form
function
express
differ
system
without
motif
fusion
recombin
subunit
vaccin
technolog
promis
approach
develop
novel
influenza
vaccin
due
advantag
safeti
manufactur
vaccin
shown
efficaci
influenza
attenu
inactiv
vaccin
recent
studi
shown
recombin
viruslik
particl
vlp
vaccin
induc
protect
immun
viru
model
anim
howev
product
recombin
vlp
vaccin
timeconsum
plant
shown
one
promis
altern
pharmaceut
product
platform
robust
scalabl
lowcost
safe
rapid
vaccin
develop
day
nicotiana
benthamiana
perform
use
agroinfiltrationelicit
protect
immun
respons
influenza
viru
context
studi
fuse
motif
trimer
design
physic
mix
nd
optim
ratio
gener
oligomer
synthet
format
trimer
express
n
benthamiana
purifi
via
affin
chromatographi
imac
character
via
crosslink
reaction
incub
mixtur
nm
nd
variou
ratio
optim
mixtur
trimer
nd
design
nd
screen
use
western
blot
haemagglutin
assay
base
bind
capac
trimer
surfac
nd
abil
trimer
agglutin
chicken
red
blood
cell
rbc
respect
success
conjug
trimer
onto
surfac
nd
analys
use
particl
analys
sdspage
western
blot
trimer
protein
nd
optim
mixtur
nd
inject
mice
immunogen
induc
optim
mixtur
nd
mice
compar
trimer
well
nd
accord
elisa
western
blot
dna
sequenc
encod
amino
acid
aa
haemagglutinin
subtyp
influenza
antigen
uniprot
access
optim
express
tobacco
plant
synthes
commerci
genecust
europ
luxembourg
provid
vector
design
gene
replac
synthes
dna
sequenc
encod
ectodomain
aa
gener
express
cassett
control
camv
promot
express
cassett
prtra
vector
shown
fig
subclon
via
hindiii
cleavag
shuttl
vector
shuttl
vector
introduc
agrobacterium
strain
agrobacterium
infiltr
express
recombin
protein
describ
phan
et
al
bacteria
harbour
shuttl
vector
hcpro
vector
suspend
infiltr
buffer
mm
nmorpholino
ethanesulfon
acid
me
mm
ph
n
benthamiana
plant
week
old
infiltr
complet
submerg
plant
agrobacteriumcontain
cup
stand
insid
desicc
appli
partial
vacuum
min
next
plant
kept
greenhous
h
h
dark
day
leaf
sampl
harvest
store
six
day
vacuum
infiltr
agrobacterium
leaf
sampl
harvest
treat
liquid
nitrogen
homogen
use
commerci
blender
total
protein
extract
tri
buffer
mm
ph
extract
clarifi
via
centrifug
twice
min
clear
extract
mix
agaros
resin
previous
wash
twice
water
tri
buffer
mix
min
mixtur
appli
chromatographi
column
thereaft
column
wash
two
time
wash
buffer
mm
mm
nacl
mm
imidazol
ph
recombin
protein
elut
column
elut
buffer
mm
mm
nacl
mm
imidazol
ph
put
dialysi
bag
concentr
peg
dialyz
pb
mm
nacl
mm
kcl
mm
mm
ph
overnight
determin
multimer
state
purifi
protein
crosslink
reaction
perform
follow
method
describ
weldon
et
al
briefli
recombin
protein
mix
bi
sulfosuccinimidyl
suber
mm
final
concentr
incub
min
room
temperatur
crosslink
reaction
stop
ad
ph
final
concentr
mm
incub
min
room
temperatur
crosslink
protein
separ
sdspage
reduc
condit
blot
analys
via
western
blot
use
mention
anticmyc
monoclon
antibodi
diamond
powder
diamond
innov
usa
surfacefunction
oxygen
contain
group
via
harsh
treatment
strong
oxid
acid
mixtur
volum
volum
microwav
heat
describ
previou
public
treatment
conduct
microwav
reactor
w
model
discov
cem
h
end
microwav
heat
precaut
care
taken
ensur
residu
strong
acid
dilut
prior
collect
nd
safe
oper
microwav
reactor
place
chemic
fumehood
protect
oper
exposur
oxid
nd
particl
first
thoroughli
resuspend
assist
sonic
concentr
mgml
find
best
condit
maintain
activ
protein
sampl
well
obtain
good
resuspend
nanoconjug
protein
coat
variou
nd
ratio
ww
test
differ
buffer
pb
sonic
h
appli
coat
size
distribut
zetapotenti
nd
protein
coat
measur
use
particl
analys
delsa
nanoc
backman
coulter
usa
size
distribut
zeta
potenti
measur
barend
proteinco
fnd
resuspend
concentr
evalu
aggreg
tendenc
proteinco
nd
complex
salt
buffer
sampl
resuspend
pb
follow
particl
size
measur
proteinco
nd
particl
first
wash
twice
deioniz
water
remov
loos
bound
moieti
salt
excess
protein
molecul
elut
sdspage
load
buffer
sd
dtt
bromophenol
blue
ph
glycerol
supernat
contain
protein
load
onto
gel
cast
run
protein
gel
perform
accord
laemmli
use
biorad
miniprotean
ii
western
blot
perform
follow
protocol
describ
gahrtz
et
al
imagej
use
analys
western
blot
result
base
intens
protein
band
shape
surfac
properti
surfaceoxid
nd
nd
complex
character
via
tem
imag
nd
nd
complex
resuspend
concentr
mgml
particl
solut
coat
onto
tem
plate
imag
acquisit
haemagglutin
assay
perform
follow
world
organ
anim
health
recommend
detail
pb
ad
well
plastic
vbottom
microtit
plate
next
antigen
ad
first
well
plastic
vbottom
microtit
plate
serial
dilut
made
across
entir
row
total
last
dilut
discard
furthermor
chicken
rbc
ad
well
incub
plate
min
result
read
endpoint
dilut
caus
complet
haemagglutin
defin
one
haemagglutin
unit
hau
test
mous
sera
microtit
plate
immunopl
maxisorp
nalgen
nunc
intern
roskild
denmark
coat
ng
influenza
antigen
nibsc
pb
mm
nacl
mm
mm
ph
incub
overnight
block
wv
bovin
serum
albumin
bsa
vv
pb
pbst
h
specif
mous
sera
dilut
time
wv
bsa
pbst
anti
haemagglutininha
monoclon
mous
antibodi
sinobiolog
inc
concentr
appli
elisa
plate
incub
h
serum
dilut
measur
triplic
plate
wash
time
pbst
follow
addit
goat
antimous
igg
conjug
horseradish
peroxidas
hrp
dilut
time
wv
bsa
pbst
incub
h
enzymat
substrat
ultra
tmbelisa
substrat
solut
thermo
fisher
scientif
lithuania
ad
min
incub
reaction
stop
via
hcl
mous
sera
appli
elisa
condit
absorb
signal
measur
nm
elisa
valu
mous
sera
normalis
use
monoclon
mous
standard
haemagglutininha
antibodi
sinobiolog
inc
standard
curv
built
use
valu
correspond
differ
concentr
antibodi
control
valu
bsa
solid
phase
subtract
amount
specif
anti
haemagglutininha
antibodi
sera
calcul
use
standard
curv
protein
separ
sdspage
gel
transfer
pvdf
membran
millipor
via
semidri
fast
blotter
thermo
scientif
block
wv
fatfre
milk
powder
dissolv
pb
buffer
mm
nacl
mm
kcl
mm
mm
ph
membran
incub
h
room
temperatur
addit
dilut
monoclon
anticmyc
antibodi
later
hrp
conjug
goat
antimous
igg
secondari
antibodi
dilut
detect
igg
mous
antibodi
ng
purifi
influenza
antigen
nibsc
load
lane
one
sdspage
gel
protein
separ
accord
molecular
weight
transfer
pvdf
membran
millipor
via
semidri
fast
blotter
thermo
fisher
scientif
usa
h
block
wv
fatfre
milk
powder
dissolv
pb
buffer
mm
nacl
mm
kcl
mm
mm
ph
lane
membran
separ
via
cut
singl
stripe
incub
h
room
temperatur
dilut
mixtur
five
mice
sera
group
group
group
group
antimous
haemagglutininha
antibodi
sinobiolog
inc
china
use
posit
control
p
next
membran
incub
h
room
temperatur
addit
dilut
hrp
conjug
goat
antimous
igg
secondari
antibodi
specif
signal
visual
incub
membran
dark
dab
thermo
scientif
pierc
hydrogen
peroxid
min
statist
analys
elisa
test
perform
use
ttest
sigma
plot
softwar
mean
differ
sampl
data
compar
present
x
standard
deviat
sd
p
valu
less
defin
signific
differ
effici
express
plant
cell
sequenc
encod
ectodomain
aa
influenza
antigen
strain
synthes
optim
codon
clone
express
cassett
fig
protein
recombinantli
express
fusion
trimer
motif
control
camv
recombin
protein
contain
cmyc
tag
downstream
detect
via
western
blot
tag
purif
via
imac
kdel
motif
ctermin
end
retain
protein
endoplasm
reticulum
er
function
binari
vector
contain
valid
via
transient
express
n
benthamiana
leav
determin
via
sdspage
reduc
condit
western
blot
use
anticmyc
monoclon
antibodi
fig
western
blot
analysi
indic
recombin
success
express
plant
appar
molecular
weight
shown
fig
higher
expect
size
predict
polypeptid
sequenc
explain
fact
glycosyl
influenc
run
behaviour
electrophoret
separ
obtain
recombin
experi
protein
contain
ctermin
histidin
tag
purifi
plant
leav
via
imac
sampl
step
purif
procedur
collect
analys
via
sdspage
western
blot
use
monoclonalanti
cmyc
antibodi
fig
western
blot
analysi
reveal
one
band
correspond
elut
fraction
result
indic
protein
highli
enrich
tobacco
plant
leav
success
purifi
purif
protein
oligomer
state
protein
determin
via
crosslink
reaction
use
chemic
watersolubl
homobifunct
crosslink
react
primari
amin
protein
form
stabl
amid
bond
oligomer
protein
expos
crosslink
subunit
multimer
protein
form
direct
evid
close
proxim
follow
crosslink
reaction
product
separ
gradient
sdspage
reduc
condit
blot
immun
detect
use
anticmyc
monoclon
antibodi
immunoblot
result
fig
reveal
band
molecular
weight
approxim
kda
crosslink
via
result
indic
exclus
trimer
protein
size
distribut
tem
analysi
nd
use
present
experi
shown
fig
clearli
observ
mixtur
nd
particl
wide
rang
size
nm
diamet
fig
size
distribut
nd
suggest
two
particl
aggreg
may
variat
size
differ
particl
inde
tem
analysi
illustr
fig
show
singl
nd
aggreg
nd
particl
addit
see
tem
imag
nd
round
individu
particl
differ
shape
also
note
fig
nd
form
bad
aggreg
salt
solut
pb
studi
use
nd
oxid
mixtur
strong
acid
includ
volum
ratio
harsh
acid
treatment
nd
decor
oxygencontain
function
group
carboxyl
acid
thu
neg
charg
surfac
nd
complex
synthes
via
simpl
mix
protein
solut
nd
suspens
h
sonic
differ
proteinnd
ratio
ww
test
find
best
synthet
condit
figur
show
chang
size
distribut
nd
coat
trimer
protein
ww
ratio
proteinco
nd
sampl
resuspend
pb
particl
size
measur
clearli
seen
fig
b
nd
particl
increas
size
approxim
nm
diamet
protein
coat
result
indic
signific
amount
protein
conjug
onto
surfac
nd
particl
compar
size
distribut
nd
nd
pb
also
reveal
protein
coat
help
prevent
fast
aggreg
nanoparticl
physiolog
condit
analys
chang
surfac
chemistri
nd
coat
measur
zetapotenti
nd
comparison
nd
complex
found
type
particl
neg
charg
surfac
furthermor
chang
zetapotenti
mv
nd
mv
nd
fig
prove
exist
trimer
onto
surfac
nd
protein
coat
analys
nd
conjug
via
sdspage
western
blot
fig
imagej
use
analys
western
blot
result
base
intens
protein
band
measur
nd
ratio
rang
ww
bind
capac
trimer
surfac
nd
proport
increas
amount
nd
present
complex
howev
ad
nd
correspond
nd
ratio
ww
bind
capac
trimer
surfac
nd
increas
may
explain
bind
capac
trimer
surfac
nd
satur
biolog
activ
purifi
trimer
haemagglutinin
protein
mix
nd
assess
use
haemagglutin
assay
result
haemagglutin
assay
shown
fig
result
indic
abil
agglutin
chicken
rbc
increas
use
mixtur
trimer
nd
correspond
nd
ratio
ww
confirm
nd
retain
function
rbc
bind
abil
mixtur
nd
ratio
ww
exhibit
highest
haemagglutin
activ
hau
per
mixtur
nd
contrast
mixtur
nd
ratio
ww
ha
titer
decreas
hau
due
unknown
reason
pb
nd
ratio
ww
pb
nd
ratio
agglutin
chicken
rbc
ha
titer
mean
certain
amount
nd
bind
receptor
surfac
rbc
creat
network
rbc
suggest
hypothesi
nd
may
act
noncompetitivecompetit
inhibitor
much
nd
present
mixtur
nd
nd
ratio
ww
observ
free
trimer
abl
agglutin
rbc
ha
titer
less
ha
titer
nd
mixtur
ratio
ww
therefor
result
indic
optim
nd
ratio
ww
trimer
group
mixtur
trimer
nd
formul
contain
respect
correspond
ratio
ww
group
well
nd
group
separ
dilut
pb
use
immun
mice
fig
specif
igg
antibodi
respons
sera
immun
mice
evalu
via
elisa
western
blot
measur
specif
igg
amount
mous
sera
via
elisa
shown
fig
serum
measur
triplic
sera
dilut
monoclon
mous
anti
haemagglutininha
antibodi
appli
standard
specif
immun
respons
measur
booster
immun
group
nd
group
pb
nd
group
control
valu
bsa
antigen
solid
phase
elisa
subtract
respons
recalcul
accord
standard
valu
anti
antibodi
sera
see
materi
method
mean
valu
includ
standard
deviat
bar
repres
dot
squar
mean
everi
group
individu
determin
compar
ttest
fig
elisa
result
show
statist
signific
differ
mous
group
group
p
notabl
immun
elisa
result
fig
illustr
nd
group
induc
higher
amount
specif
igg
antibodi
mous
sera
respect
trimer
group
contrast
specif
igg
antibodi
detect
mous
sera
produc
immun
pb
nd
group
five
mice
sera
collect
immun
group
nd
pb
nd
mix
use
primari
antibodi
detect
purifi
western
blot
fig
indic
stronger
igg
antibodi
respons
induc
mice
vaccin
nd
group
trimer
group
specif
antibodi
respons
strongli
increas
immun
shown
western
blot
analysi
contrast
specif
igg
antibodi
respons
induc
mice
control
group
vaccin
pb
nd
group
vaccin
shown
elicit
highli
effici
protect
immun
respons
influenza
viru
high
molecular
weight
format
form
selfassembl
accord
previou
studi
efficaci
neutral
antibodi
elicit
recombin
ha
protein
avian
influenza
viru
highmolecularweight
ha
oligom
elicit
strongest
neutral
antibodi
respons
follow
ha
trimer
monom
show
minim
efficaci
gener
ha
oligom
seem
recombin
ha
fragment
easili
form
function
conform
trimer
oligomer
structur
format
function
molecul
ha
may
influenc
addit
sequenc
present
studi
trimer
protein
form
fuse
trimer
heptad
repeat
sequenc
deriv
wildtyp
dimer
repeat
found
saccharomyc
cerevisia
gener
oligomer
synthet
format
trimer
physic
mix
mixtur
nd
wide
rang
size
nm
diamet
optim
ratio
current
studi
shown
facil
success
conjug
onto
surfac
nd
obtain
simpli
mix
togeth
character
nd
complex
via
size
measur
sdspage
westernblot
haemagglutin
assay
show
recombin
protein
noncoval
conjug
onto
nd
surfac
activ
protein
well
preserv
conjug
previou
studi
shown
isol
cell
repres
highmolecularweight
vlp
nanoparticl
approxim
nm
like
compris
ha
trimer
data
suggest
major
form
oligomer
vlp
may
import
immunogen
present
studi
chang
surfac
chemistri
nd
trimer
coat
promin
sinc
zetapotenti
nd
nd
mv
respect
sinc
glycoprotein
like
protein
interact
nd
glycanexpress
region
protein
conjug
onto
nd
surfac
glycan
neg
charg
molecul
expos
water
nd
carbonbas
nanoparticl
like
interact
protein
hydrophob
forc
also
observ
membran
protein
thu
glycan
express
domain
mostli
epitop
protein
preserv
allow
recognit
immun
cell
optim
mixtur
trimer
nd
screen
western
blot
haemagglutin
assay
follow
remov
free
protein
antigenload
particl
recov
data
suggest
mixtur
nd
ratio
ww
exhibit
highest
bind
capac
trimer
surfac
nd
agglutin
chicken
rbc
ha
titer
higher
ha
titer
free
trimer
notabl
synthet
exhibit
haemagglutin
activ
minimum
total
protein
amount
fig
lower
minimum
total
protein
amount
vlp
exhibit
haemagglutin
activ
previou
studi
hu
et
al
pushko
et
al
respect
contrast
present
studi
free
trimer
agglutin
chicken
rbc
minimum
amount
total
protein
data
suggest
nd
present
potenti
effect
relat
biofunct
vlp
shown
haemagglutin
activ
expect
immun
physic
mixtur
nd
contain
nd
formul
elicit
significantli
higher
igg
antibodi
free
trimer
protein
shown
western
blot
elisa
result
suggest
potenti
effect
inher
nd
nd
may
form
oligomer
synthet
enhanc
present
immun
process
transport
drain
lymph
node
stronger
igg
immun
respons
previou
studi
synthet
vlp
prepar
mix
nm
gold
nanoparticl
spike
protein
compar
inocul
free
protein
vaccin
synthet
vlp
show
enhanc
lymphat
antigen
deliveri
stronger
antibodi
titer
increas
splenic
tcell
respons
reduc
infectionassoci
symptom
avian
model
corona
viru
infect
vlp
act
adjuv
carri
peptid
sequenc
antigen
present
cell
thu
enhanc
antigen
process
pathway
surfacemodifi
diamond
nanoparticl
conform
stabil
proteinspeptid
nd
also
provid
high
degre
surfac
exposur
protein
antigen
elicit
strong
specif
immun
respons
observ
thu
explain
adjuv
effect
summari
synthet
form
mix
trimer
antigen
synthet
nd
optim
ratio
induc
assembl
viruslik
nanoparticl
viral
trimer
antigen
cover
particul
core
result
demonstr
success
prepar
synthet
vlp
via
physic
mix
nd
trimer
vaccin
physic
mixtur
trimer
protein
nd
elicit
stronger
specificigg
immun
respons
free
trimer
protein
nd
potenti
improv
vaccin
efficaci
nd
continu
address
challeng
remain
immunolog
provid
innov
strategi
broadli
appli
develop
differ
vaccin
futur
